Related references
Note: Only part of the references are listed.Hepatocellular Carcinoma With Extrahepatic Metastasis Clinical Features and Prognostic Factors
Koji Uchino et al.
CANCER (2011)
Cancer immunotherapy: Progress and challenges in the clinical setting
Hassane M. Zarour et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Critical role of c-Jun N-terminal kinase in regulating bFGF-induced angiogenesis in vitro
Shen Kaikai et al.
JOURNAL OF BIOCHEMISTRY (2011)
Significance of heparanase-1 and vascular endothelial growth factor in adrenocortical carcinoma angiogenesis: potential for therapy
Yun-ze Xu et al.
ENDOCRINE (2011)
Screening and identification of novel B cell epitopes in human heparanase and their anti-invasion property for hepatocellular carcinoma
Jian-min Yang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Hepatocellular Carcinoma - Epidemiological Trends and Risk Factors
Kerstin Schuette et al.
DIGESTIVE DISEASES (2009)
Cell Surface Heparan Sulfate Released by Heparanase Promotes Melanoma Cell Migration and Angiogenesis
Madhuchhando Roy et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Alternatively spliced Spalax heparanase inhibits extracellular matrix degradation, tumor growth, and metastasis
Nicola J. Nasser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Heparanase: One molecule with multiple functions in cancer progression
Israel Vlodavsky et al.
CONNECTIVE TISSUE RESEARCH (2008)
Molecular targeted therapies in hepatocellular carcinoma
Josep M. Llovet et al.
HEPATOLOGY (2008)
Basement membrane proteins play an important role in the invasive processes of human pancreatic cancer cells
Hirozumi Sawai et al.
JOURNAL OF SURGICAL RESEARCH (2008)
Heparanase Facilitates Cell Adhesion and Spreading by Clustering of Cell Surface Heparan Sulfate Proteoglycans
Flonia Levy-Adam et al.
PLOS ONE (2008)
PI-88 and novel heparan sulfate mimetics inhibit angiogenesis
Vito Ferro et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2007)
A review of the use of trastuzumab (Herceptin®) plus vinorelbine in metastatic breast cancer
A. Chan
ANNALS OF ONCOLOGY (2007)
Heparanase: a target for drug discovery in cancer and inflammation
E. A. McKenzie
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis
Huajun Zhao et al.
CANCER RESEARCH (2006)
Heparanase:: A new metastasis-associated antigen recognized in breast cancer patients by spontaneously induced memory T lymphocytes
Nora Sommerfeldt et al.
CANCER RESEARCH (2006)
Development of heparanase inhibitors for anti-cancer therapy
Hua-Quan Miao et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis
Neta Ilan et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase
F Levy-Adam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A decade's studies on metastasis of hepatocellular carcinoma
ZY Tang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Twenty-year trends of primary liver cancer incidence rates in an urban Chinese population
XS Hao et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2003)
Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development
I Vlodavsky et al.
SEMINARS IN CANCER BIOLOGY (2002)
Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: A prospective study
RTP Poon et al.
ANNALS OF SURGERY (2001)
Expression of vascular endothelial growth factor in surgical specimens of hepatocellular carcinoma
FQ An et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2000)
Share Paper
